Side-by-side comparison of AI visibility scores, market position, and capabilities
Miami global cruise (NYSE: CCL) at record $25B FY2024 revenue (+15%), EBITDA $6.1B (+40%); 90+ ships 9 brands, 2025 guidance ~20% earnings growth, "nearly 2/3 booked at all-time pricing" competing with Royal Caribbean.
Carnival Corporation & plc is a Miami, Florida-based global cruise company — publicly traded on both the New York Stock Exchange (NYSE: CCL) and the London Stock Exchange (LSE: CCL) as an S&P 500 Consumer Discretionary component — operating the world's largest fleet of cruise ships across nine distinct cruise brands serving North American, European, and Australian vacationers: Carnival Cruise Line, Princess Cruises, Holland America Line, Seabourn, Costa Cruises, AIDA Cruises, P&O Cruises (UK), P&O Cruises (Australia), and Cunard, through approximately 160,000 employees and 90+ ships calling on 700+ ports in all seven continents. In fiscal year 2024 (ending August 2024), Carnival achieved record total revenues of $25 billion (+15% year-over-year), net income of $1.9 billion, and record adjusted EBITDA of $6.1 billion (+40%) — with management guiding approximately 20% earnings growth for 2025, supported by nearly two-thirds of the year already booked at all-time high pricing and occupancy levels at the time of guidance. CEO Josh Weinstein, who assumed leadership in 2022, has led the company's post-COVID financial recovery from the industry's most severe disruption — a 15-month fleet shutdown (March 2020 to June 2021) that required Carnival to raise $30+ billion in emergency debt and equity capital — toward the current record performance cycle.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.